Records containing: Post-transplant Lymphoproliferative Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-17Nonmyeloablative Hematopoietic Stem Cell Transplantation for Patients With High-Risk Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Phase II Trial of Combined Immunosuppression Before and After Transplantation
-
CLINICAL_TRIALS study record update · 2017-03-22Phase II Study of Single Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD)
-
CLINICAL_TRIALS study record update · 2016-07-14Hematopoietic Stem Cell Transplantation Using Alternate Donor Umbilical Cord Blood Options
-
CLINICAL_TRIALS study record update · 2016-01-08Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-11-13A Pilot Trial of Vorinostat Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease Following Unrelated Donor Hematopoietic Stem Cell Transplantation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-11-07A Phase 1 Study of RO4929097 (NSC749225) in Combination With Capecitabine in Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-04-29A Phase I Study of MK-2206, an AKT Inhibitor, in Pediatric Patients With Recurrent or Refractory Solid Tumors or Leukemia
-
CLINICAL_TRIALS study record update · 2014-03-17A Phase 1/Pharmacokinetic Study of Sunitinib in Patients With Cancer Who Also Have HIV and Are on HAART Therapy
-
CLINICAL_TRIALS study record update · 2013-12-03Phase I Dose-Escalation Study of Azacitidine (Vidaza) and Bortezomib (Velcade) in T-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2013-05-16A Phase I Study of PXD101 in Combination With 17-AAG in Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-05-03A Phase 1 Study of PXD101 in Combination With Bortezomib (PS-341) in Patients With Advanced Solid Tumors and Lymphoma
-
CLINICAL_TRIALS study record update · 2013-01-25A Phase I/II Study: Zevalin Radioimmunotherapy for Patients With Post Transplant Lymphoproliferative Disease Following Solid Organ Transplantation
-
CLINICAL_TRIALS study record update · 2013-01-17A Phase I Study Of Yttrium-Ibritumomab Tiuxetan (90Y Zevalin, Yttrium (90)-Anti-CD20, NSC # 710085) Preceded By Rituximab In Children With Recurrent/Refractory CD20 Positive Lymphoma
-
CLINICAL_TRIALS study record update · 2010-12-09A Phase I Study of the Combination of Lenalidomide With the Histone Deacetylase Inhibitor, Vorinostat in Hodgkin and Non Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2010-08-09High-dose Busulfan, High-dose Cyclophosphamide, and Allogeneic Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndromes, Multiple Myeloma and Lymphoma